Splicing imbalances in basal-like breast cancer underpin perturbation of cell surface and oncogenic pathways and are associated with patients’ survival
Filipe Grácio(Innsbruck Medical University), Emanuele de Rinaldis(Target (United States)), Brian Burford(Guy's Hospital), Anita Grigoriadis(London Cancer), Cheryl Gillett(King's College London), Andrew Tutt(Institute of Cancer Research), Aisyah Mohd Noor(Guy's Hospital), Anca Mera(Guy's and St Thomas' NHS Foundation Trust), Pierfrancesco Marra(King's College London), Sarah E. Pinder(St Thomas' Hospital), Patrycja Gazińska(London Cancer)
Cited by 14
Related Papers
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
|The Lancet|2010|2.3k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
|Nature Communications|2016|1.8k